This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sunnybrook Research Institute. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Tumor Response Prediction by William Tyler Tran
Introduction
William Tyler Tran is an accomplished inventor based in Toronto, Canada. He has made significant contributions to the field of medical imaging, particularly in the prediction of tumor responses to chemotherapy. His innovative work aims to enhance treatment outcomes for cancer patients.
Latest Patents
William Tyler Tran holds a patent for "Systems and methods for prediction of tumor response to chemotherapy using pre-treatment quantitative ultrasound parameters." This patent describes systems and methods that utilize quantitative ultrasound (QUS) techniques to generate imaging biomarkers. These biomarkers are instrumental in assessing the prediction of tumor response to various chemotherapy treatment regimens. By subtyping tumors that exhibit resistance to specific chemotherapy regimens prior to drug exposure, his work provides valuable insights for predicting tumor responses and evaluating the prognostic value of particular treatment options. He has 1 patent to his name.
Career Highlights
William Tyler Tran is affiliated with the Sunnybrook Research Institute, where he continues to advance research in medical imaging and oncology. His work is pivotal in bridging the gap between imaging technology and cancer treatment, ultimately aiming to improve patient care.
Collaborations
He collaborates with notable colleagues, including Hadi Tadayyon and Gregory J Czarnota, who contribute to the research and development of innovative solutions in the field.
Conclusion
William Tyler Tran's contributions to the prediction of tumor responses through innovative imaging techniques represent a significant advancement in cancer treatment. His work not only enhances the understanding of tumor behavior but also aims to improve the efficacy of chemotherapy regimens for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
